Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
202.7 USD | +0.44% | -6.77% | -19.41% |
Apr. 17 | DiaMedica Therapeutics Launches Late-Stage Trial of Potential Stroke Treatment | MT |
Apr. 12 | Penumbra, Inc. : The underdog in healthcare |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.41% | 7.81B | |
+72.65% | 12.28B | |
+14.98% | 7.19B | |
-5.13% | 5.23B | |
+5.78% | 4.94B | |
+17.02% | 4.24B | |
-25.36% | 3.97B | |
-40.56% | 2.24B | |
-3.47% | 1.92B | |
-8.13% | 1.71B |
- Stock Market
- Equities
- PEN Stock
- News Penumbra, Inc.
- Transcript : Penumbra, Inc., Q4 2021 Earnings Call, Feb 22, 2022